This company listing is no longer active
CLS1 Stock Overview
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
McKesson Europe AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €24.40 |
| 52 Week High | €24.50 |
| 52 Week Low | €19.80 |
| Beta | 0.13 |
| 11 Month Change | 0.83% |
| 3 Month Change | 0.83% |
| 1 Year Change | 9.91% |
| 33 Year Change | -6.51% |
| 5 Year Change | -7.58% |
| Change since IPO | -6.51% |
Recent News & Updates
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)
Dec 23
These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
Sep 01Recent updates
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)
Dec 23These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
Sep 01These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
May 19McKesson Europe (HMSE:CLS1) Could Be Struggling To Allocate Capital
Jan 27Capital Allocation Trends At McKesson Europe (HMSE:CLS1) Aren't Ideal
Sep 07McKesson Europe (HMSE:CLS1) Will Be Looking To Turn Around Its Returns
Apr 29What You Need To Know About McKesson Europe AG's (HMSE:CLS1) Investor Composition
Mar 20Is McKesson Europe AG (HMSE:CLS1) A Risky Dividend Stock?
Feb 13
Shareholder Returns
| CLS1 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | -1.3% |
| 1Y | 9.9% | 15.7% | 7.4% |
Return vs Industry: CLS1 exceeded the German Healthcare industry which returned -12.8% over the past year.
Return vs Market: CLS1 exceeded the German Market which returned 1.4% over the past year.
Price Volatility
| CLS1 volatility | |
|---|---|
| CLS1 Average Weekly Movement | 0.7% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CLS1 has not had significant price volatility in the past 3 months.
Volatility Over Time: CLS1's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1835 | 6,808 | Sebastian Ring | www.mckesson.eu/mck-en |
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products.
McKesson Europe AG Fundamentals Summary
| CLS1 fundamental statistics | |
|---|---|
| Market cap | €4.96b |
| Earnings (TTM) | -€54.30m |
| Revenue (TTM) | €9.26b |
0.5x
P/S Ratio-91.3x
P/E RatioIs CLS1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLS1 income statement (TTM) | |
|---|---|
| Revenue | €9.26b |
| Cost of Revenue | €8.46b |
| Gross Profit | €792.30m |
| Other Expenses | €846.60m |
| Earnings | -€54.30m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 8.56% |
| Net Profit Margin | -0.59% |
| Debt/Equity Ratio | 0.3% |
How did CLS1 perform over the long term?
See historical performance and comparison